1
|
Bergkvist M, Stephens C, Schilling T, Wang A, Yu X, Goodwin E, Golden L, Kristensen A, Klein M. Aromatic L-amino acid decarboxylase deficiency: a systematic review. FUTURE NEUROLOGY 2022. [DOI: 10.2217/fnl-2022-0012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Aim: To gain greater knowledge regarding the natural history of aromatic L-amino acid decarboxylase (AADC) deficiency, a genetic disorder that causes severe deficits in motor and cognitive development. Materials & methods: A systematic literature review was performed of all case reports and clinical studies published through December 2019 of patients with AADC deficiency. The data were summarized descriptively. Results: The search identified 94 publications that described 237 unique patients. Mean (standard deviation) age at diagnosis was 3.2 (±5.7) years and 16 deaths were reported. Most patients (57%) received the standard of care therapies, which showed limited efficacy in this patient population. Conclusion: AADC deficiency is a devastating disease and prospectively defined natural history studies are warranted to further understand this disease.
Collapse
Affiliation(s)
| | | | | | - Antonia Wang
- PTC Therapeutics, Inc., South Plainfield, NJ 07080, USA
| | - Xiaojin Yu
- PTC Therapeutics, Inc., South Plainfield, NJ 07080, USA
| | | | - Lee Golden
- PTC Therapeutics, Inc., South Plainfield, NJ 07080, USA
| | | | - Matthew Klein
- PTC Therapeutics, Inc., South Plainfield, NJ 07080, USA
| |
Collapse
|